Literature DB >> 23846249

Evaluation of a commercial assay for ADAMTS13 activity measurement.

Sandrine Thouzeau1, Sophie Capdenat, Alain Stépanian, Paul Coppo, Agnès Veyradier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23846249     DOI： 10.1160/TH13-05-0393

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

Review 1.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

2.  Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay.

Authors:  Nicolas Beranger; Sandrine Benghezal; Bérangère S Joly; Sophie Capdenat; Adeline Delton; Alain Stepanian; Paul Coppo; Agnès Veyradier
Journal:  Res Pract Thromb Haemost       Date:  2020-12-15

Review 3.  The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries.

Authors:  Murtadha Al-Khabori; Faisal Alsayegh; Hasan Al Yaseen; Sabir Hussien; Amar Lal; Muna Al Rasheed; Mohammad Al Bader; Salam Al Kindi; Mahmoud Marashi
Journal:  Oman Med J       Date:  2022-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.